BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30365872)

  • 1. exSSSRs (extracellular S100 soil sensor receptors)-Fc fusion proteins work as prominent decoys to S100A8/A9-induced lung tropic cancer metastasis.
    Kinoshita R; Sato H; Yamauchi A; Takahashi Y; Inoue Y; Sumardika IW; Chen Y; Tomonobu N; Araki K; Shien K; Tomida S; Torigoe H; Namba K; Kurihara E; Ogoshi Y; Murata H; Yamamoto KI; Futami J; Putranto EW; Ruma IMW; Yamamoto H; Soh J; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
    Int J Cancer; 2019 Jun; 144(12):3138-3145. PubMed ID: 30365872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. exMCAM-Fc, an S100A8/A9-mediated-metastasis blocker, efficiently reduced the number of circulating tumor cells that appeared in the blood flow.
    Tomonobu N; Kinoshita R; Sakaguchi M
    Mol Biol Rep; 2020 Jun; 47(6):4879-4883. PubMed ID: 32383137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
    Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
    Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis.
    Kinoshita R; Sato H; Yamauchi A; Takahashi Y; Inoue Y; Sumardika IW; Chen Y; Tomonobu N; Araki K; Shien K; Tomida S; Torigoe H; Namba K; Kurihara E; Ogoshi Y; Murata H; Yamamoto KI; Futami J; Putranto EW; Ruma IMW; Yamamoto H; Soh J; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
    Int J Cancer; 2019 Jul; 145(2):569-575. PubMed ID: 30414170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroplastin-β mediates S100A8/A9-induced lung cancer disseminative progression.
    Sumardika IW; Chen Y; Tomonobu N; Kinoshita R; Ruma IMW; Sato H; Kondo E; Inoue Y; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Futami J; Putranto EW; Hibino T; Nishibori M; Toyooka S; Sakaguchi M
    Mol Carcinog; 2019 Jun; 58(6):980-995. PubMed ID: 30720226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
    Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
    Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidine-Rich Glycoprotein Suppresses the S100A8/A9-Mediated Organotropic Metastasis of Melanoma Cells.
    Tomonobu N; Kinoshita R; Wake H; Inoue Y; Ruma IMW; Suzawa K; Gohara Y; Komalasari NLGY; Jiang F; Murata H; Yamamoto KI; Sumardika IW; Chen Y; Futami J; Yamauchi A; Kuribayashi F; Kondo E; Toyooka S; Nishibori M; Sakaguchi M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-1,3-Galactosyl-
    Sumardika IW; Youyi C; Kondo E; Inoue Y; Ruma IMW; Murata H; Kinoshita R; Yamamoto KI; Tomida S; Shien K; Sato H; Yamauchi A; Futami J; Putranto EW; Hibino T; Toyooka S; Nishibori M; Sakaguchi M
    Oncol Res; 2018 Apr; 26(3):431-444. PubMed ID: 28923134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
    Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
    Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A8/A9: From basic science to clinical application.
    Pruenster M; Vogl T; Roth J; Sperandio M
    Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models.
    Cho E; Mun SJ; Kim HK; Ham YS; Gil WJ; Yang CS
    Acta Pharmacol Sin; 2024 Mar; 45(3):581-593. PubMed ID: 38040838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
    Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
    Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatment.
    Taub CJ; Lippman ME; Hudson BI; Blomberg BB; Diaz A; Fisher HM; Nahin ER; Lechner SC; Kwak T; Hwang GH; Antoni MH
    Cancer; 2019 May; 125(10):1717-1725. PubMed ID: 30633331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis.
    Tomonobu N; Kinoshita R; Sakaguchi M
    Transl Oncol; 2020 Apr; 13(4):100753. PubMed ID: 32193075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2.
    Ghavami S; Kerkhoff C; Chazin WJ; Kadkhoda K; Xiao W; Zuse A; Hashemi M; Eshraghi M; Schulze-Osthoff K; Klonisch T; Los M
    Biochim Biophys Acta; 2008 Feb; 1783(2):297-311. PubMed ID: 18060880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
    Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
    Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of an endogenous anti-inflammatory protein in mice enhances colonization of B16F10 melanoma cells in the lungs.
    Saha A; Lee YC; Zhang Z; Chandra G; Su SB; Mukherjee AB
    J Biol Chem; 2010 Apr; 285(14):10822-31. PubMed ID: 20118237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.